CSF Biomarker and PIB-PETDerived Beta-Amyloid Signature Predicts Metabolic, Gray Matter, and Cognitive Changes in Nondemented Subjects

Author： Ewers Michael   Insel Philip   Jagust William J.   Shaw Leslie   Trojanowski J John Q.   Aisen Paul   Petersen Ronald C.   Schuff Norbert   Weiner Michael W.  

Publisher： Oxford University Press

ISSN： 1460-2199

Source： Cerebral Cortex, Vol.22, Iss.9, 2012-09, pp. : 1993-2004

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Oxidative Mechanisms in beta-Amyloid Cytotoxicity

By Davis J.B.  

Neurodegeneration, Vol. 5, Iss. 4, 1996-12 ,pp. : 441-444

Academic Press

Access to resources Recommend Favorite

Brain beta-amyloid measures and magnetic resonance imaging atrophy both predict time-to-progression from mild cognitive impairment to Alzheimers disease

By Jack Clifford R.  

Brain, Vol. 133, Iss. 11, 2010-11 ,pp. : 3336-3348

Oxford University Press

Access to resources Recommend Favorite

Beta-Amyloid Toxicity in Embryonic Rat Astrocytes

By Assis-Nascimento Poincyane   Jarvis Karen   Montague Jeremy   Mudd Laura  

Neurochemical Research, Vol. 32, Iss. 9, 2007-09 ,pp. : 1476-1482

Springer Publishing Company

Access to resources Recommend Favorite

Beta-Amyloid, Oxidative Stress and Down Syndrome

By  

Current Alzheimer Research, Vol. 3, Iss. 5, 2006-12 ,pp. : 521-528

Bentham Science Publishers

Access to resources Recommend Favorite

Alzheimer's Disease: From Acetylcholine to beta-Amyloid

By Palmer A.M.   Francis P.T.  

Neurodegeneration, Vol. 5, Iss. 4, 1996-12 ,pp. : 379-380

Academic Press

Access to resources Recommend Favorite